Related Experiment Video

Updated: Mar 18, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

3.0K

A cross-scale multimodal framework identifies clinically actionable immunotherapy biomarkers in melanoma through bulk

Wuda Huoshen1,2, Kun Yuan3, Junkai Xiong2

  • 1Department of Dermatology, Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, China.

Human Genomics
|March 17, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Cutaneous melanomaMulti-omicsPrognostic modelSingle-cell transcriptomicsSpatial transcriptomicsTCGA-SKCM cohortTherapeutic targetsTranscriptome-wide association studyTumor microenvironment characteristics

More Related Videos

DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma09:58

DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma

Published on: June 6, 2025

1.2K
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

3.2K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K